Cargando…
The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance, obesity, and dyslipidemia. NAFLD encompasses a wide range of states from the simple accumulation of triglycerides in the hepatocytes to serious states accompanied by inflammation and fibrosis in the liver. De no...
Autor principal: | Moon, Young-Ah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368123/ https://www.ncbi.nlm.nih.gov/pubmed/28116873 http://dx.doi.org/10.3803/EnM.2017.32.1.6 |
Ejemplares similares
-
GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction
por: Yang, Xiaoli, et al.
Publicado: (2017) -
Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway
por: Sun, Hong, et al.
Publicado: (2013) -
The Gene-Gene Interaction of INSIG-SCAP-SREBP Pathway on the Risk of Obesity in Chinese Children
por: Liu, Fang-Hong, et al.
Publicado: (2014) -
Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis
por: Kawamura, Satoshi, et al.
Publicado: (2022) -
PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus
por: Xu, Daqian, et al.
Publicado: (2015)